Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Josef Schoell Insider Profile
4 Followers
Josef Schoell, Chief Financial Officer at Cara Therapeutics, holds 28.00K shares in Cara Therapeutics (Ticker: CARA). Most recently, Josef Schoell Bought $4,000 shares of Cara Therapeutics on Jul 28, 2017 for an estimated value of 9.00K.
Josef Schoell Cara Therapeutics (CARA)Chief Financial Officer
Cara Therapeutics (CARA)
Chief Financial Officer
Ranked #7,488 out of 98,743 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+68.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Financial Officer
Roles that Josef Schoell holds in companies
Most Profitable Insider Trade
The most profitable trade made by Josef Schoell
Josef Schoell's Trading History
List of latest transactions for each holding click on a transaction to see Josef Schoell's performance on stock
You May Also Like
Josef Schoell insider profile FAQ
What is the percentage of profitable transactions made by Josef Schoell?
The percentage of profitable transactions made by Josef Schoell is 75%.
What is the average return per transaction made by Josef Schoell?
The average return per transaction made by Josef Schoell is 68.40%.
What stocks does Josef Schoell hold?
Josef Schoell holds: CARA stocks.
What was Josef Schoell’s latest transaction?
Josef Schoell latest transaction was an Informative Buy of $9.00K.
What was Josef Schoell's most profitable transaction?
Josef Schoell’s most profitable transaction was an Informative Buy of CARA stock on March 17, 2016. The return on the trade was 207.80%.
What is Josef Schoell's role in Cara Therapeutics?
Josef Schoell's role in Cara Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.